We are led by an experienced leadership team with a proven track record in the biopharmaceutical industry. Collectively, our leadership team has contributed to drug discovery and development as well as approval, launch and commercialization of multiple specialty medicines.

Polygon
Lynne Powell
Chief Executive Officer
Polygon
Dr. Andreas Maetzel
Chief Medical Officer
Polygon
Katalin Ferenczi
General Manager, Europe
Polygon
Marion McGlynn
Vice President, Project and portfolio management
Polygon
Dr. Suzanne Thornton-Jones
Vice President, Regulatory Affairs
Polygon
Jana Spes
Vice President, CMC
Polygon
Dr. Roger Ilagan
Vice President, Research
Polygon
Lester Szymanik
Head of Finance
Polygon
Darren Brayton
Executive Director, Quality
Polygon
Dr. Elizabeth Manning Duus
Vice President, Clinical Development
Polygon
Shirley Steiner
Executive Director, Clinical Operations